NCT00005074View on ClinicalTrials.gov

Flavopiridol in Treating Patients With Previously Untreated or Relapsed Mantle Cell Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

January 24, 2000

Primary Completion Date

February 20, 2002

Study Completion Date

September 22, 2008

Conditions
Lymphoma
Interventions
DRUG

alvocidib

Trial Locations (4)

B3H 1V7

Nova Scotia Cancer Centre, Halifax

L8V 5C2

Cancer Care Ontario-Hamilton Regional Cancer Centre, Hamilton

M5G 2C4

Toronto General Hospital, Toronto

M9N 1N8

Humber River Regional Hospital, Weston

Sponsors
All Listed Sponsors
lead

NCIC Clinical Trials Group

NETWORK